GORDON R KELLEY
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology SHAWNEE MISSION, KS NPI 1548225535
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology KS ABBVIE INC. All categories
General Payments — all program years on this page
$9,072.39
- Category: General Payments
- Program years: PY2018–2024
- Record count: 634
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,686.73 across 103 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,686.73 | 103 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $453.68 | 41 |
| ARGENX US, INC. | $105.82 | 5 |
| EMD Serono, Inc. | $86.35 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $81.87 | 5 |
| Amneal Pharmaceuticals LLC | $80.01 | 4 |
| Lundbeck LLC | $71.86 | 3 |
| UCB, Inc. | $66.28 | 4 |
| Genentech USA, Inc. | $65.54 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $61.56 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $57.95 | 2 |
| JAZZ PHARMACEUTICALS INC. | $55.78 | 3 |
| Kyowa Kirin, Inc. | $55.58 | 3 |
| Teva Pharmaceuticals USA, Inc. | $55.13 | 3 |
| Lilly USA, LLC | $51.27 | 3 |
| Ultragenyx Pharmaceutical Inc. | $50.40 | 3 |
| Ceribell, Inc. | $47.10 | 2 |
| EISAI INC. | $44.46 | 2 |
| Biogen, Inc. | $41.89 | 2 |
| Abbott Laboratories | $39.73 | 2 |
| HOSPIRA, INC. | $34.20 | 2 |
| PFIZER INC. | $28.83 | 2 |
| MDD US Operations, LLC | $20.38 | 1 |
| ACADIA Pharmaceuticals Inc | $16.67 | 1 |
| Grifols USA, LLC | $14.39 | 1 |
By program year
Records — PY2024 (103)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.